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ABSTRACT
Despite long-standing supplementation of iodine in Iran, the prevalence of goitre among general people 
remains high in some regions. The study investigated the role of iron status in the aetiology of goitre in 
school children in Isfahan, Iran. Two thousand three hundred and thirty-one school children were selected 
by multi-stage random sampling. Thyroid size was estimated by inspection and palpation. Urinary iodine 
concentration (UIC) and serum ferritin (SF) were measured. Overall, 32.9% of the children had goitre. The 
median UIC was 195.5 µg/L. The mean±SD of SF in the goitrous and non-goitrous children was 47.65±42.51 
and 44.55±37.07 µg/L respectively (p=0.52). The prevalence of iron deficiency in goitrous and non-goitrous 
children was 9.6% and 3.1% respectively (p=0.007). Goitre is still prevalent in school children of Isfahan. 
However, their median UIC was well in the accepted range. Iron deficiency is associated with goitre in a 
small group of goitrous children. The role of goitrogens should also be investigated in this region.
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INTRODUCTION
Iodine-deficiency disorders (IDDs) are still a 
major health problem estimated to affect 750 
million people worldwide (1). The spectrum of 
these disorders includes endemic goitre, hypo-
thyroidism, endemic cretinism, and other con-
genital anomalies (2). One of micronutrients 
that can potentially influence IDDs is iron (3-5). 
Deficiencies of iron and iodine are major over-
lapping public-health problems in the develop-
ing world, and many children are at a high risk 
of both goitre and iron-deficiency anaemia (6). 
Iron deficiency adversely affects the physiology 
of thyroid, and supplementation of iron may im-
prove the efficacy of oral iodized oil in goitrous 
children with iron-deficiency anaemia (7).
Endemic goitre is present in most parts of Iran (8), 
and iodine deficiency is considered a contribut-
ing factor for endemic goitre in the country (9). 
The National Committee for Control of IDD was 
formed in 1989 by the Ministry of Health and Medi- 
cal Education. The production and distribution of 
iodized salt (40 mg of potassium iodide per kg of 
sodium chloride) began, and education of policy-
makers, health personnel, and public on IDD was 
initiated in 1990. However, a survey of consump-
tion of iodized salt showed that less than 50% of 
the population consumed iodized salt in 1993 with 
the mean urinary iodine of 5.0-8.2 µg/dL. There-
fore, the first law requiring the mandatory iodiza-
tion of all salts for household use was promulgated 
in 1994 (10). Isfahan is a city in central part of Iran 
with an approximate population of 2,000,000. The 
prevalence of goitre in Isfahan was estimated to be 
92% in girls and 85% in boys in 1989 (11). Results 
of another study in 1997 showed that the preva-
lence of goitre among children aged 6-18 years in 
Isfahan was 62% (12).
The present study was carried out to estimate the 
prevalence of goitre and status of iodine and in-
vestigate the role of iron deficiency as a possible 
contributor to endemic goitre in school children of   
Isfahan, 15 years after the initiation of salt-iodiza-
tion programme.Hashemipour M et al. Goitre and serum ferritin
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MATERIALS AND METHODS
This cross-sectional study was performed on school 
children in Isfahan in 2005. Subjects were enrolled 
by multistage cluster random sampling (n=2,331). 
We excluded children with a history of exposure 
to radioactive iodine, thyroid surgery, or significant 
underlying disease, such as cardiopulmonary, liver 
or renal problems based on available medical re-
cords and interviewing parents and teachers.
Two endocrinologists performed goitre grading ac-
cording to the classification of the World Health 
Organization/United Nations Children’s Fund/In-
ternational Council for the Control of Iodine Defi-
ciency (WHO/UNICEF/ICCIDD) (1): 
Grade 0: No palpable or visible goitre.
Grade 1: A goitre that is palpable but not visible 
when the neck is in normal position (i.e. the thy-
roid is not visibly enlarged).
Grade 2: A swelling in the neck that is clearly visible 
when the neck is in normal position and is con-
sistent with an enlarged thyroid when the neck is   
palpated.
Written informed consent was taken from parents 
of all children. The Ethics Committee of the Is-
fahan Endocrine and Metabolism Research Center 
approved the study. A trained staff member drew 
a venous blood sample in a sitting position. The 
blood samples were transported on dry ice to the 
reference laboratory of the Isfahan Endocrine and 
Metabolic Research Center where these were stored 
at -70 °C until analysis. Urine samples were also 
collected for measuring iodine excretion. All blood 
and urine assays were performed within a median 
of 26 hours after sampling. The same person per-
formed each assay using the same method. 
Urine iodine concentration (UIC) was measured 
by the digestion method based on a modification 
of Sandell-Kolthoff reaction (1,13). Serum ferritin 
(SF) was measured using immunoradiometric as-
say. Iron deficiency was defined as SF of <15 µg/
L. Serum T4 was measured by radioimmunoassay 
(Iran Kavoshyar Co., Tehran, Iran). Concentration 
of TSH in serum was measured using immunora-
diometric assay (Iran Kavoshyar Co., Tehran, Iran). 
The normal range of T4 was 4.5-12 µg/dL, and for 
TSH (thyroid-stimulating hormonic), it was 0.3-3.9 
mU/L. Anti-thyroglobulin antibody (anti-Tg Ab) 
and anti-thyroperoxidase antibody (anti-TPO Ab) 
were measured by Rapid ELISA (Genesis Diagnos-
tics, Littleport, UK). Intra- and inter-assay coef-
ficient of variation for anti-Tg Ab was <12%, and 
for anti-TPO Ab, it was 7% and 5% respectively. 
Anti-Tg and anti-TPO concentrations of over 100 
IU/mL and 75 IU/mL respectively were considered 
to be positive.
Analysis of data 
Quantitative variables are presented as mean±standard 
deviation (SD). Normality of data distribution was 
assessed with Kolmogorov-Smirnov test. Indepen-
dent sample t-test and one-way analysis of vari-
ance were used for comparing measurements in 
different groups. Parameters not normally distrib-
uted were compared by Mann-Whitney test. The 
prevalence of iron deficiency between goitrous and 
normal children was compared by chi-square test. 
Pearson’s correlation was used for finding cor-
relation between SF and different quantitative 
variables; p value of <0.05 was considered sig-
nificant. All analyses were performed using the 
SPSS software (version 15) (SPSS Corp, Chicago, IL, 
USA). 
RESULTS
Two thousand three hundred and thirty-one school 
children were enrolled in the study, with a female-
to-male ratio of 1.60. Their age ranged from six to 
13 years. The mean age±SD was 9.39±1.18 years for 
girls and 9.47±1.12 years for boys. Overall, 32.9%   
of the children (n=767) were classified as goitrous 
(Table 1). The prevalence of goitre among the girls 
Table 1. Thyroid size determined by inspection and palpation in school children of Isfahan, Iran
Subjects
Thyroid size
No. Grade 0 (%) Grade 1 (%) Grade 2 (%)
Boys 898 66.3 27.3 6.4
Girls 1,433 67.6 29.0 3.4
All 2,331 67.1 28.3 4.6
Grade 0=No palpable or visible goitre; Grade 1=A goitre that is palpable but not visible when the neck 
is in normal position; Grade 2=A swelling in the neck that is clearly visible when the neck is in normal 
position and is consistent with an enlarged thyroid when the neck is palpatedHashemipour M et al. Goitre and serum ferritin
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was 32.4%, and 33.7% of the boys were goitrous 
(p=0.51). 
UIC was measured in 454 randomly-selected 
children. The mean±SD and median UIC were 
220.66±17.33 µg/L and 195.50 µg/L respectively. 
Seventy-two children (15.8%) had UIC<100 μg/L, 
and 3.7% had UIC <50 μg/L. One hundred and six-
teen children (25.6%) had UIC between 200 and 
300 µg/L, and 23.8% had UIC of more than 300 
µg/L. UIC in the goitrous (n=152) and non-goi-
trous (n=302) children did not differ significantly. 
Comparing the mean UIC in the goitrous and non-
goitrous children based on different sex groups did 
not show any significant difference either.
Ninety-four Grade 2 goitrous children (51 boys, 43 
girls) and 326 non-goitrous children (149 boys, 177 
girls) were randomly selected as cases and controls 
respectively for the measurement of SF.
The mean±SD of SF in the goitrous and non-goitrous 
children was 47.65±42.51 µg/L and 44.55±37.07 µg/L 
respectively (p=0.52). The SF level in the goitrous 
and non-goitrous girls was 42.53±36.23 µg/L and 
46.76±45.20 µg/L respectively (p=0.57). SF in the   
goitrous and non-goitrous boys was 51.96±47.03 
µg/L and 41.93±23.99 µg/L respectively (p=0.15). 
In the goitrous and non-goitrous groups, there were 
nine (9.6%) and 10 (3.1%) children with iron defi-
ciency respectively [odds ratio (OR) 3.35, 95% con-
fidence interval (CI) 1.32-8.50, p=0.007)]. Children   
in the first distributional quartile of SF concentra-
tion had a lower UIC than children in the fourth 
quartile (189.66±104.60 vs 227.54±122.68 μg/L, 
p=0.02). SF correlated with UIC (r=0.17, p=0.001). 
It did not, however, correlate with T4 and TSH lev-
els.
Serum TSH and T4 were measured in 485 ran-
domly-selected children. Six (1.2%) children had 
subclinical hyperthyroidism, and 82 (16.9%) had 
subclinical hypothyroidism. Clinical hyper- or hy-
pothyroidism was not detected in any children 
tested. The goitrous children had significantly low-
er T4 levels than the non-goitrous ones (8.20±1.66 
vs 8.84±1.48 μg/dL, p<0.001). There was no signifi-
cant difference between TSH levels in the goitrous 
and non-goitrous children. The mean SF levels 
did not differ significantly between euthyroid and 
subclinically-hypothyroid children. Iron-deficient 
children had a higher prevalence of subclinical hy-
pothyroidism than iron-sufficient ones (31.6% vs 
17.1%, p=0.24).
While one iron-deficient child (10.5%) had positive 
anti-Tg Ab, 5.8% (n=23) of iron-sufficient children 
had positive anti-Tg Ab (p=0.40). The prevalence of 
positive anti-TPO Ab was higher in children with 
iron deficiency than iron-sufficient ones (10.5% vs 
4.8%, p=0.26).
The mean serum TSH, T4, UIC, and thyroid auto-
antibodies in subjects with and without iron defi-
ciency did not differ significantly (Table 2). There 
was also no significant difference in these variables 
by different SF concentration quartiles (Table 3). 
DISCUSSION
According to the present study, the prevalence of 
goitre among school children in Isfahan has de-
creased from about 89% in 1989 (11) and 62% in 
1997 (12) to 32.9% in 2005. This implies that io-
dine deficiency has been the most important cause 
of endemic goitre and also shows the effective role 
of the legislation for salt iodization in controlling 
goitre. However, goitre is still endemic in this area 
and is a severe public-health problem according to 
the WHO/UNICEF/ICCIDD-recommended cri-
teria (1). According to the criteria, the indicator of 
elimination of iodine deficiency is a median value 
for UIC of 100 μg/L, and UIC should not be below 
50 μg/L in more than 20% of samples (1). In the 
study population, the median UIC was 195.50 μg/
L, and 3.7% of the population had UIC <50 μg/L, 
implying that there is no biochemical iodine defi-
ciency in the overall population. More than 25% 













(n=19) 3.04±1.41 8.25±1.46 92.53±252.06 87.49±286.32 19.95±14.47
Iron-sufficient 
(n=401) 2.85±2.76 8.72±1.55 27.57±109.73 56.40±319.80 21.84±11.56
Significance NS NS NS NS NS
NS=Not significant; Tg=Thyroglobulin; TPO=Thyroperoxidase; TSH=Thyroid-stimulating hormone; 
UIC=Urinary iodine concentrationHashemipour M et al. Goitre and serum ferritin
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of the study children had iodine intake more than 
adequate, and 23.8% had excessive iodine intake. 
This indicates the risk of iodine-induced hyperthy-
roidism within 5-10 years after the introduction 
of iodized salt to susceptible groups (1). It was re-
ported that, after prophylaxis with iodine salt in 
Zaire, 14% of patients had undetectable serum TSH 
values (14). In the present study, 1.2% of the chil-
dren had subclinical hyperthyroidism, and there 
were no case of clinical hyperthyroidism. We sug-
gest that the iodine content of salt in this region be 
monitored at regular intervals.
In areas with iodine-deficient people, multiple nu-
tritional and environmental influences may con-
tribute to the prevalence and severity of IDD. We 
showed that the school children with goitre in Is- 
fahan had lower serum selenium levels than non-
goitrous ones (15). However, there was no signifi-
cant difference in concentration of serum retinol as 
an indicator of vitamin A status between goitrous 
and non-goitrous school children in Isfahan (16). 
There are limited reports on interaction between 
the goitre rate and the iron status (17). In the Phili- 
ppines, there was no difference in goitre rate be-
tween anaemic and non-anaemic subjects (18). In 
two studies in Iran and Ethiopia, no correlation was 
found between the iron status and the goitre rate or 
thyroid hormone levels (19,20). In a clinical trial on 
goitrous children with and without iron deficiency, 
Zimmermann et al. found that the therapeutic res- 
ponse to oral iodine was impaired in goitrous chil-
dren with iron-deficiency anaemia, suggesting that 
the presence of iron-deficiency anaemia in children 
limits the effectiveness of iodine-intervention pro-
grammes (3). In another trial, addition of encapsu-
lated iron to iodized salt improved the efficacy of 
iodine in goitrous children with a high prevalence 
of anaemia (21). In the present study, we investi-
gated the role of iron deficiency as a contributor 
to endemic goitre in school children in Isfahan. 
Although the mean SF level in the goitrous and 
non-goitrous children did not differ significantly, 
the goitrous children had a higher iron-deficiency 
rate than the non-goitrous ones. A similar finding 
was reported from a recent study in Iran where iron 
deficiency was associated with an increased rate of 
goitre (22). The mechanism by which the iron sta-
tus influences thyroid and iodine metabolism is un-
clear (23). Iron deficiency decreases plasma T4 and 
T3 concentrations, reduces peripheral conversion 
of T4 to T3, and may increase concentrations of 
TSH (7,24-26). Subjects with lower iron stores may 
have higher reverse T3 concentration (27). The two 
initial steps of thyroid hormone synthesis are cata-
lyzed by thyroperoxidases that are dependent on 
iron (28). In addition, iron deficiency may alter the 
control of thyroid physiology in the central nervous 
system and modify nuclear T3 binding (24,29). In 
the present study, there was no significant differ-
ence in the mean TSH and T4 levels between the 
iron-deficient and the iron-sufficient subjects. This 
is in agreement with a previous study by Azizi et al. 
(17) and in contrast to another study by Dabbagh-
manesh et al. in which iron-deficient patients had 
a significantly higher TSH level and lower free T4 
concentrations than those with a normal SF level 
(22). However, in our study, children in the first 
distributional quartile of SF had lower UIC levels 
than children in the fourth distributional quartile 
of SF, and this may be a possible explanation for 
the higher rate of goitre in the iron-deficient sub-
jects. The impairment of thyroid peroxidase (TPO) 
activity may also influence thyroid metabolism. 
Iron-deficient rats had sharply reduced TPO activi- 
ty (23). Although, in the present study, we did not 
determine the TPO activity, the iron-deficient chil-
dren had higher anti-TPO Ab levels than iron-suf-
ficient ones.
The main limitation of our study was that we cate- 
gorized participants into goitrous and non-goi-
Table 3. Concentration of different variables based on quartile of SF in Grade 2 goitrous and non-












SF≤27.6 2.65±1.48 8.58±1.63 37.29±130.82 29.55±128.66 189.66±104.60
27.6<SF≤38.3 3.02±1.50 8.58±1.52 14.31±32.51 21.69±67.62 227.07±107.80
38.3<SF≤50.7 3.11±4.81 8.68±1.42 48.62±164.57 137.45±539.77 225.09±128.07
SF>50.7 2.62±1.40 8.94±1.59 21.54±109.12 42.05±292.15 227.54±122.68
Significance NS NS NS NS NS
NS=Not significant; SF=Serum ferritin; Tg=Thyroglobulin; TPO=Thyroperoxidase; TSH=Thyroid-
stimulating hormone; UIC=Urinary iodine concentrationHashemipour M et al. Goitre and serum ferritin
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trous groups by inspection and palpation. It has 
been stated that, in areas of mild-to-moderate IDD, 
the sensitivity and specifity of palpation are poor 
(30). Classification of children into different goitre 
groups would have been more accurate, had we 
used thyroid ultrasonography instead of inspec-
tion and palpation. The evaluation of body iron 
status in our study was based only on the SF level. 
It would have been better to use other iron status 
parameters, such as serum iron, total iron-bind-
ing capacity, serum-soluble transferrin receptor, or 
transferrin concentration besides SF level. Lack of 
any statistically significant difference between SF 
levels in goitrous and non-goitrous school children 
could be attributed to the small sample size which 
is another limitation of the present study. SF can be 
falsely elevated during an infection. This can be ad-
justed with serum C-reactive protein (CRP) levels, a 
marker of infection. Although we did not measure 
CRP, the study children were free of any clinical in-
fection when blood sampling was done.  
We have shown that goitre is still a public-health 
problem in Isfahan. Iron deficiency is associated 
with goitre only in a small proportion of goitrous 
children, and these children may benefit from iron 
supplementation. Other factors, such as goitrogens 
or autoimmunity, may have a role in the still high 
prevalence of goitre in school children of Isfahan.
ACKNOWLEDGEMENTS
The Bureau for Research, Isfahan University of 
Medical Sciences, funded the study. The authors 
are thankful to the authorities of the provincial and 
local education offices, all the staff working with 
the project, and students and their parents for their 
cooperation.
REFERENCES
1.  World Health Organization. Assessment of iodine de-
ficiency disorders and monitoring their elimination. 
A guide for programme managers. 2nd ed. Geneva: 
World Health Organization, 2001. 107 p. (WHO/
NHD/01.1).
2.  Saggiorato E, Mussa A, Sacerdote C, Rossetto R, Arec-
co F, Origlia C et al. Thyroid volume and urinary 
iodine excretion in the schoolchild population of 
a northwestern Italian sub-Alp metropolitan area. J 
Endocrinol Invest 2004;27:516-22.
3.  Zimmermann M, Adou P, Torresani T, Zeder C, Hurrell 
R. Persistence of goiter despite oral iodine supplemen-
tation in goitrous children with iron deficiency ane-
mia in Côte d’Ivoire. Am J Clin Nutr 2000;71:88-93.
4.  Zimmermann MB, Wegmueller R, Zeder C, Chaouki 
N, Biebinger R, Hurrell RF et al. Triple fortification of 
salt with microcapsules of iodine, iron, and vitamin 
A. Am J Clin Nutr 2004;80:1283-90.
5.  Hess SY, Zimmermann MB. The effect of micronutri-
ent deficiencies on iodine nutrition and thyroid me-
tabolism. Int J Vitam Nutr Res 2004;74:103-15.
6.  Hess SY, Zimmermann MB, Adou P, Torresani T, 
Hurrell RF. Treatment of iron deficiency in goitrous 
children improves the efficacy of iodized salt in Côte 
d‘Ivoire. Am J Clin Nutr 2002;75:743-8.
7.  Zimmermann M, Adou P, Torresani T, Zeder C, Hur-
rell R. Iron supplementation in goitrous, iron-defi-
cient children improves their response to oral iodized 
oil. Eur J Endocrinol 2000;142:217-23.
8.  Emami A, Shahbazi H, Sabzevari M, Gawam Z, Sarkis-
sian N, Hamedi P et al. Goiter in Iran. Am J Clin Nutr 
1969;22:1584-8.
9.  Kimiagar M, Azizi F, Navai L, Yassai M, Nafarabadi T. 
Survey of iodine deficiency in a rural area near Teh-
ran: association of food intake and endemic goitre. 
Eur J Clin Nutr 1990;44:17-22.
10. Azizi F, Sheikholeslam R, Hedayati M, Mirmiran P, 
Malekafzali H, Kimiagar M et al. Sustainable control 
of iodine deficiency in Iran: beneficial results of the 
implementation of the mandatory law on salt iodiza-
tion. J Endocrinol Invest 2002;25:409-13.
11. Azizi F, Kimiagar M, Nafarabadi T, Yassai M. Current 
status of iodine deficiency disorders in the Islamic Re-
public of Iran. EMR Health Surv J 1990;8:23-7.
12. Aminorroaya A, Amini M, Rezvanian H, Kachoie A, 
Sadri G, Mirdamadi M et al. Effects of iodized salt 
consumption on goiter prevalence in Isfahan: the 
possible role of goitrogens. Endocr Pract 2001;7:95-8.
13. Pino S, Fang SL, Braverman LE. Ammonium persul-
fate: a safe alternative oxidizing reagent for measur-
ing urinary iodine. Clin Chem 1996;42:239-43.
14. Bourdoux PP, Ermans AM, Mukalay wa MA, Filetti 
S, Vigneri R. Iodine-induced thyrotoxicosis in Kivu, 
Zaire. Lancet 1996;347:552-3.
15. Keshteli AH, Hashemipour M, Siavash M, Amini M. 
Selenium deficiency as a possible contributor of goi-
ter in schoolchildren of Isfahan, Iran. Biol Trace Elem 
Res 2009;129:70-7.
16. Hashemipour M, Keshteli AH, Dastjerdi MS, Amini 
M, Kelishadi R, Koleini N. Vitamin A status does not 
contribute to the residual goiter in schoolchildren of 
Isfahan, an iodine replenished area. Int J Food Sci Nutr 
2008;60(Suppl 5):19-27.
17. Azizi F, Mirmiran P, Sheikholeslam R, Hedayati 
M,Rastmanesh R. The relation between serum ferri-
tin and goiter, urinary iodine, and thyroid hormone 
concentration. Int J Vitam Nutr Res 2002;72:296-9.
18. Florentino RF, Tanchoco CC, Rodriguez MP, Cruz Hashemipour M et al. Goitre and serum ferritin
JHPN 142
AJ, Molano WL. Interactions among micronutrient 
deficiencies and undernutrition in the Philippines. 
Biomed Environ Sci 1996;9:348-57.
19. Siavash Dastjerdi M, Hashemipour M, Rezvanian H, 
Kazemi F, Najafian A, Mohammady M et al. Iron de-
ficiency in goitrous schoolchildren of Semirom, Iran. 
Horm Res 2006;66:45-50. 
20. Wolde-Gebriel Z, West CE, Gebru H, Tadesse AS, 
fisseha T, Gabre P et al. Interrelationship between vi-
tamin A, iodine, and iron status in schoolchildren in 
Shoa region, central Ethiopia. Br J Nutr 1993;70:593-
607.
21. Zimmermann MB, Zeder C, Chaouki N, Torresani 
T, Saad A, Hurrell RF. Addition of microencapsu-
lated iron to iodized salt improves the efficacy of io-
dine in goitrous, iron-deficient children: a random-
ized, double-blind, controlled trial. Eur J Endocrinol 
2002;147:747-53.
22. Dabbaghmanesh MH, Sadegholvaad A, Ejtehadi F, 
Ranjbar-Omrani G. The role of iron deficiency in per-
sistent goiter. Arch Iranian Med 2008;11:157-61.
23. Hess SY, Zimmermann MB, Arnold M, Langhans W, 
Hurrell RF. Iron deficiency anemia reduces thyroid 
peroxidase activity in rats. J Nutr 2002;132:1951-5.
24. Beard JL, Borel MJ, Derr J. Impaired thermoregulation 
and thyroid function in iron-deficiency anemia. Am J 
Clin Nutr 1990;52:813-9.
25. Beard JL, Brigham DE, Kelley SK, Green MH. Plasma 
thyroid hormone kinetics are altered in iron-deficient 
rats. J Nutr 1998;128:1401-8.
26. Dillman E, Gale C, Green W, Johnson DG, Mackler 
B, Finch C. Hypothermia in iron deficiency due to 
altered triiodothyronine metabolism. Am J Physiol 
1980;239:R377-81.
27. Eftekhari MH, Keshavarz SA, Jalali M, Elguero E, Esh-
raghian MR, Simondon KB. The relationship between 
iron status and thyroid hormone concentration in 
iron-deficient adolescent Iranian girls. Asia Pac J Clin 
Nutr 2006;15:50-5.
28. Ackrell BA, Maguire JJ, Dallman PR, Kearney EB. Ef-
fect of iron deficiency on succinate and NADH-ubi-
quinone oxidoreductases in skeletal muscle mito-
chondria. J Biol Chem 1984;259:10053-9.
29. Smith SM, Finley J, Johnson LK, Lukaski C. Indi-
ces of in vivo and in vitro thyroid hormone me-
tabolism in iron-deficient rats. Nutr Res 1994;14:729-
39.
30. Zimmermann M, Saad A, Hess S, Torresani T, Cha-
ouki N. Thyroid ultrasound compared with World 
Health Organization 1960 and 1994 palpation crite-
ria for determination of goiter prevalence in regions 
of mild and severe iodine deficiency. Eur J Endocrinol 
2000;143:727-31.